Case study: to complete a course of cladribine or have AHSCT abroad?

A patient with rapidly-evolving severe MS is having doubts about the decision to be treated with cladribine. Should she abort the cladribine and have AHSCT?

Case study

I am a 49-year-old female who is a non-smoker, a non-drinker and I am currently unemployed. I, unfortunately, lost my job during the pandemic and shortly afterwards went blind in my left eye due to optic neuritis. I was treated with steroids and my vision recovered. 

My MS history: I had a normal brain MRI in 2000 when…

This post is for paying subscribers